Back to Results

Airsculpt Technologies Inc (AIRS)

AirSculpt Technologies, Inc. is a NASDAQ-listed common stock company in the healthcare sector that operates through its subsidiaries as a holding company for EBS Intermediate Parent LLC. The business focuses on body contouring procedure services in the United States and Canada. Its offerings include AirSculpt, a minimally invasive treatment designed to remove fat and tighten skin in targeted areas, as well as AirSculpt+, which is described as a precision-focused fat removal and skin-tightening procedure. The company also provides AirSculpt Smooth for cellulite removal, fat removal procedures across areas such as the stomach, back, and buttocks, and fat transfer procedures used to enhance areas including the buttocks, breasts, hips, aging hands, and others. Additional procedures include Power BBL, Up a Cup, and Hip Flip. AirSculpt Technologies was founded in 2012 and is headquartered in Miami Beach, Florida.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-AIRS
$1.78
23.8% Upside
Undervalued
$4
177.8% Upside
Bargain
Fair
0.0%
1.0x
0.7x
103.8 M
155.5 M
40.4%
23.3%
1.5
-6.5%
Valuation • Fair Value

Airsculpt Technologies Inc (NASDAQ-AIRS) Fair Value by Valuation Model

Review the available estimates for Airsculpt Technologies Inc (NASDAQ-AIRS), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.78

Estimated upside of 23.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.88

Discounted cash flow valuation reference.

EPV Fair Value

$0.84

Earnings power value estimate.

Comps Fair Value

$1.92

Comparable-company valuation reference.

Analyst Price Target

$4

Analysts imply upside of 177.8%.

How to read these valuation models

Use the 6 available valuation references for Airsculpt Technologies Inc (NASDAQ-AIRS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Airsculpt Technologies Inc (NASDAQ-AIRS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

150.7 M

Current operating scale indicator.

Revenue Forecast

151.1 M

Forward revenue estimate.

EBITDA

6.286 M

Current operating profitability reference.

EBITDA Forecast

12.187 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Airsculpt Technologies Inc (NASDAQ-AIRS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Airsculpt Technologies Inc (NASDAQ-AIRS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Altman Z-Score

1.5

Lower score that deserves closer risk review.

FCF / Net Income

-6.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Airsculpt Technologies Inc (NASDAQ-AIRS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Airsculpt Technologies Inc (NASDAQ-AIRS)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Airsculpt Technologies Inc (NASDAQ-AIRS). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Airsculpt Technologies Inc (NASDAQ-AIRS) Stock Forecast & Technical Outlook

Review Airsculpt Technologies Inc (NASDAQ-AIRS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Airsculpt Technologies Inc (NASDAQ-AIRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Airsculpt Technologies Inc (NASDAQ-AIRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Airsculpt Technologies Inc (NASDAQ-AIRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Airsculpt Technologies Inc (NASDAQ-AIRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Airsculpt Technologies Inc (NASDAQ-AIRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Airsculpt Technologies Inc (NASDAQ-AIRS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Airsculpt Technologies Inc (NASDAQ-AIRS) has a Hold consensus, with 0 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 2
Sell 0
FAQ • Fast Investor Answers

Airsculpt Technologies Inc (NASDAQ-AIRS) Stock FAQ

Data-supported answers about Airsculpt Technologies Inc (NASDAQ-AIRS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.78
Estimated upside 23.8%
Valuation Rating
Undervalued
Estimated upside of 23.8%
Analyst Target
$4
Implied upside 177.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Airsculpt Technologies Inc (NASDAQ-AIRS) is $1.78. This implies an estimated upside of 23.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 23.8% versus the current market price.

The available analyst price target for Airsculpt Technologies Inc (NASDAQ-AIRS) is $4. The analyst target implies estimated upside of 177.8%.

The current financial health read for Airsculpt Technologies Inc (NASDAQ-AIRS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Airsculpt Technologies Inc (NASDAQ-AIRS).

The current market capitalization listed for Airsculpt Technologies Inc is 103.8 M.

The current enterprise value listed for Airsculpt Technologies Inc is 155.5 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Airsculpt Technologies Inc is NASDAQ-AIRS, and the stock is listed on NASDAQ.

Airsculpt Technologies Inc (NASDAQ-AIRS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Airsculpt Technologies Inc is 40.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Airsculpt Technologies Inc is 23.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 354.6 B
MCK NYSE McKesson Corporation Fair Value Fair Market Cap 123.8 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 106 B
CVS NYSE CVS Health Corp Fair Value Bargain Market Cap 104.1 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 93.336 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 79.663 B
COR NYSE Cencora Inc Fair Value Undervalued Market Cap 64.82 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 62.016 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 49.448 B
CNC NYSE Centene Corp Fair Value Fair Market Cap 36.719 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 29.5 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 28.026 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 22.799 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 20.59 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 13.862 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 13.723 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 12.325 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 12.258 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 11.704 B
MOH NYSE Molina Healthcare Inc Fair Value Fair Market Cap 11.285 B